Aptose Biosciences
APTO
#10437
Rank
S$5.52 M
Marketcap
S$2.17
Share price
0.00%
Change (1 day)
1,058.38%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -S$27.81 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$31.95 Million, an increase over its 2023 earnings that were of -S$66.32 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$27.81 Million-12.99%
2024 -S$31.95 Million-51.82%
2023 -S$66.32 Million22.9%
2022 -S$53.97 Million-34.91%
2021 -S$82.91 Million17.36%
2020 -S$70.65 Million107.65%
2019 -S$34.02 Million-7.73%
2018 -S$36.87 Million160.68%
2017 -S$14.15 Million-20.27%
2016 -S$17.74 Million28.71%
2015 -S$13.79 Million
2013 -S$7.82 Million
2010 -S$6.66 Million-8.31%
2009 -S$7.26 Million
2006 -S$13.46 Million-156.93%
2005 S$23.63 M-185.16%
2004 -S$27.76 Million458.58%
2003 -S$4.97 Million-63.66%
2002 -S$13.68 Million-8.04%
2001 -S$14.87 Million16.73%
2000 -S$12.74 Million294.99%
1999 -S$3.23 Million-6.51%
1998 -S$3.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-S$79.53 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-S$85.52 Million 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-S$43.1 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA